Skip to content
Search

Latest Stories

GPhC to remove pro regs from register who fail in March assessment

Provisionally registered pharmacists who fail in the March assessment will be removed from the provisional register, the General Pharmaceutical Council (GPhC) has said in its latest update to the community pharmacy employers on Thursday (April 15).

Accordingly, provisionally registered pharmacists cannot continue to work in the existing capacity after April 29 if they fail in their exams.


Candidates who appeared the registration assessment on March 17 and 18 will receive their results by 0900am on April 29.

Those who pass the GPhC assessment will remain on the provisional register until they complete their application to join the register as a pharmacist, the pharmacy regulator said.

“We realise this will be very disappointing for the people who do not pass,” GPhC director of education and standards Mark Voce said in the email, who revealed that the regulator initially considered allowing prov-regs to continue work for a a short period of time after receiving the result.

Voce said they decided against as it would not be in the “best interests of patient safety given the objective evidence that they have not, as yet, passed the assessment.”

The pharmacy regulator has said that its latest policy will have an impact on employers, if any of the prov-regs working for them fails to pass the assessment, and urged them to discuss working arrangements with any prov-reg pharmacists they employ.

The GPhC has also encouraged employers to consider the unsuccessful candidates for a different role.

The pharmacy chain Well is offering a paid day off to its provisionally registered pharmacists who are expecting their GPhC registration exam results on April 29, whereas Lloydspharmacy has encouraged its prov-regs to book their annual leave on the same day.

More For You

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Lords back amendment to exempt pharmacies from national insurance hike

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less